"The synapse is a therapeutic target, and we are determined to communicate our novel findings on the unique pharmacology of modulating synapses ... stinel programs operate in a fundamentally different ...

Myant Corp. announced it will unveil the future of human-AI interfaces at CES 2025, showcasing award-winning, next-generation technology to empower those at risk of chronic conditions to live ...